Association Between Disease Activity and C-reactive Protein to Serum Albumin Ratio in Patients with Ankylosing Spondylitis
DOI:
https://doi.org/10.56056/411Keywords:
Ankylosing spondylitis, C-reactive protein, Disease activity, Serum albuminAbstract
Background and objectives: Ankylosing spondylitis is a persistent inflammatory rheumatic condition that predominantly affects the axial skeleton. The current research aims to assess the correlation between disease activity and the C-reactive protein to serum albumin ratio among individuals diagnosed with ankylosing spondylitis.
Patients and methods: This cross-sectional study was undertaken at Sulaymaniyah Shahid Hemn Teaching Hospital. The study encompassed a cohort comprising 100 patients who were diagnosed as ankylosing spondylitis. The study was conducted between December 2022 and August 2023. By referring to the patients' medical files and by assessing the disease activity using bath ankylosing spondylitis disease activity index and ankylosing spondylitis disease activity score required data were gathered.
Results: The patients' age ranged from 20 to 60 years, and (70%) were males. The most common comorbidities included sacroiliitis in (100%) of the patients, enthesitis in (39%) of them, peripheral arthritis in (37%) of them, and dactylitis in (20%) of them. All of the patients received anti-tumor necrosis factor therapy, (21%) and (6%) also received NSAID and DMARD treatments, respectively. CRP/S. albumin CAR was found to have statistically significant relationships with BASDAI and ASDAS scores (p-value<0.001) but not with HLAB27 (p-value=0.46). It was also found that CRP/S. albumin CAR had significant correlations with BASDAI scores (p-value=0.03) and ASDAS scores (p-value<0.001).
Conclusion: C-reactive protein-to-serum albumin ratio can be utilized as a reliable indicator to assess disease activity in individuals diagnosed with ankylosing spondylitis.
Downloads
References
1. Sieper J, Braun J, Dougados M, Baeten D. Axial spondylarthritis. Nat Rev Dis Primers. 2015 Jul 9;1(1):15013.
2. Tay SH, Yeo JG, Leong JY, Albani S, Arkachaisri T. Juvenile Spondylarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation Front Med. 2021 May 20;8.
3. 3.Tsang HHL, Chung HY. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondylarthritis-Related Axial Arthritis. J Clin Rheumatol. 2017 Aug;23(5):267–72.
4. Pamukcu M, Duran T. Could C-Reactive Protein/Albumin Ratio be an Indicator of Activation in Axial Spondylarthritis J Coll Physicians Surg Pak.2021 May 1;31(5):537–41.
5. Sakellariou GT, Anastasilakis AD, Dombros NV. Association of Serum Periostin Levels with Disease Activity and Radiographic Damage, as Well as Serum Bone Formation Markers, in Patients with Ankylosing Spondylitis. Ann Rheum Dis. 2014 Jun 1;73(Suppl 2):204.2-204.
6. Sarg?n B, Gürer G, Ta?c? Bozba? G, Öztürk H. Association between serum uric acid and inflammation markers in ankylosing spondylitis patients treated with tumor necrosis factor-? or nonsteroidal anti-inflammatory drugs. Eur Res J 2019;5(1):104-108.
7. The ED-AWARENESS Study: A Prospective, Observational Cohort Study of Awareness with Paralysis in Mechanically Ventilated Patients Admitted from the Emergency Department. Ann Emerg Med. 2021 May 1;77(5):532–44. Available from: https://www.sciencedirect.com/science/article/pii/S0196064420313147/
8. Liu A, Lv H, Tan B, Shu H, Yang H, Li J, et al. Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease. Medicine 2021 Apr 9 ;100(14):e25200. Available from: https://journals.lww.com/md-journal/Fulltext/2021/04090/Accuracy_of_the_highly_sensitive_C_reactive.24.aspx/
9. 9 Chen YH, Wang L, Feng SY, Cai WM, Chen XF, Huang ZM. The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract. 2020 Jun 22; 2020:1–8.
10. 10 Pan J, Li J, Gao Y. The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals. Front Med. 2023 Apr 5;10.
11. 11.van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi:10.1002/art.1780270401/
12. 12. Nelson, D. A., Kaplan, R. M., Kurina, L. M., & Weisman, M. H. (2023). Incidence of ankylosing spondylitis among male and female United States army personnel. Arthritis Care & Research, 75(2), 332–339. https://doi.org/10.1002/acr.24774/
13. 13. Connolly, D., Fitzpatrick, C., & O’Shea, F. (2019). Disease activity, occupational participation, and quality of life for individuals with and without severe fatigue in ankylosing spondylitis. Occupational Therapy International, 2019, 3027280. https://doi.org/10.1155/2019/3027280/
14. 14. Morin, M., Hellgren, K., & Frisell, T. (2020). Familial aggregation and heritability of ankylosing spondylitis - a Swedish nested case-control study. Rheumatology (Oxford, England), 59(7), 1695–1702. https://doi.org/10.1093/rheumatology/kez519/
15. 15. Zhong, Z., Huang, Y., Liu, Y., Chen, J., Liu, M., Huang, Q., Zheng, S., Guo, X., Deng, W., & Li, T. (2021). Correlation between C-reactive protein to albumin ratio and disease activity in patients with axial spondylarthritis. Disease Markers, 2021, 6642486. https://doi.org/10.1155/2021/6642486/
16. 16. Chen, Y.-H., Huang, W.-N., Chen, Y.-M., Lai, K.-L., Hsieh, T.-Y., Hung, W.-T., Lin, C.-T., Tseng, C.-W., Tang, K.-T., Chou, Y.-Y., Wu, Y.-D., Huang, C.-Y., Hsieh, C.-W., Chen, Y.-J., Liao, Y.-W., & Chen, H.-H. (2022). The BASDAI Cut-Off for disease activity corresponding to the ASDAS scores in a Taiwanese cohort of ankylosing spondylitis. Frontiers in Medicine, 9, 856654. https://doi.org/10.3389/fmed.2022.856654/
17. 17. Nguyen, A. L., Brick, C., Liu, D., Gibson, D. J., Gibson, P. R., & Sparrow, M. P. (2024). Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel disease. JGH Open : An Open Access Journal of Gastroenterology and Hepatology, 8(4), e13059. https://doi.org/10.1002/jgh3.13059/
18. 18. Header, D. A., Aboelwafa, R. A., Elkeleny, M. R., Bedewy, E. S., & Ellakany, A. I. (2022). C-reactive protein/albumin ratio (CAR) as a marker for detecting acute severe ulcerative colitis in Egyptian patients. Revista de Gastroenterology de México (English Edition), 87(4), 447–454. https://doi.org/10.1016/j.rgmxen.2022.06.007/
19. 19. Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Frontiers in Immunology, 9, 754. https://doi.org/10.3389/fimmu.2018.00754/
20. 20. van der Heijde, D., Joshi, A., Pangan, A. L., Chen, N., Betts, K., Mittal, M., & Bao, Y. (2016). ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondylarthritis. Rheumatology (Oxford, England), 55(1), 80–88. https://doi.org/10.1093/rheumatology/kev267/
21. 21. Sundström, B., Ljung, L., & Wållberg-Jonsson, S. (2018). Exercise habits and C-reactive protein may predict development of spinal immobility in patients with ankylosing spondylitis. Clinical Rheumatology, 37(10), 2881–2885. https://doi.org/10.1007/s10067-018-4195-y/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Avin Mariwan Mohammed Saleh, Raouf Rahim Mirza
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
